3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
5
Thoracic
2
Genitourinary
2
Sarcoma
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Lymphoma
2
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Mixed Dementias
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Lewy Body Disease
1
Kidney Neoplasms
1
Dementia, Vascular
1
Dementia
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
10
pembrolizumab
9
Therapeutics
8
Flow Cytometry
6
Radiotherapy
5
Gemcitabine
5
Blood Specimen Collection
5
Surveys and Questionnaires
4
Sirolimus
4
Psychiatric Rehabilitation
4
Peripheral Blood Stem Cell Transplantation
4
Paclitaxel
4
Nivolumab
4
Methods
4
Ipilimumab
4
Filgrastim
4
Exercise
4
Drug Therapy
4
Doxorubicin
4
Capecitabine
4
copanlisib
3
aldesleukin
3
Rituximab
3
Polymerase Chain Reaction
3
Immunologic Techniques
3
Immunoglobulin G
3
Immunoenzyme Techniques
3
Fluorodeoxyglucose F18
3
Early Intervention, Educational
3
Disulfides
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Referral and Consultation
×
Lymphoid
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts